Having at least some education beyond high school is associated with a decreased risk of dying from cancer among black and white men and women, according to a study published online September 11 in the Journal of the National Cancer Institute.
Patients with end-stage kidney disease treated with high doses of folic acid and B vitamins to lower homocysteine levels did not have improvement in survival or reductions in the incidence of vascular events, according to a study in the Sept. 12 issue of JAMA.
Preliminary findings indicate a heart failure medication used by adults, carvedilol, may not significantly improve heart failure outcomes for children and adolescents, according to an article in the Sept. 12 issue of JAMA.
An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues. There was no effect on death from cardiovascular causes.
The Society for Cardiovascular Angiography and Interventions and the American College of Cardiology announced today that they will hold a unified interventional cardiology meeting in Chicago, March 29-April 1, 2008. The meeting will be known as “The SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit.” It will be held concomitantly with the ACC Annual Scientific Session.
Thanks to a $1.6 million grant from the Welch Foundation, a coalition of six Gulf Coast institutions is launching a new initiative to develop innovative computational and chemical techniques intended to speed the development of new drugs and molecular tools for biomedical science.
Takeda Pharmaceuticals North America, Inc. is aware of the review of ACTOS (pioglitazone HCl) data conducted by A. Michael Lincoff, M.D., and colleagues at the Cleveland Clinic, published in the Journal of the American Medical Association, which concluded that ACTOS is associated with a significantly lower risk of heart attack, stroke or death among a diverse population of 16,390 patients with diabetes versus control therapy.
Research here shows that an obscure form of RNA, part of the protein-making machinery in all cells, might play an important role in human cancer. These ultraconserved non-coding RNAs (UCRs) have been considered ?junk? by some researchers, but a new report in the September issue of the journal Cancer Cell indicates that this may not be the case.
A sweeping review of research studies of aspartame says there is no evidence that the non-nutritive sweetener causes cancer, neurological damage or other health problems in humans.
A new American Cancer Society study finds having at least some education beyond high school is associated with a decreased risk of cancer death. The study finds higher education levels were strongly associated with decreased cancer mortality among black men, white men, and white women.